eCite Digital Repository
Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder
Citation
Lee, CH and Sinclair, D and O'Donnell, M and Galletly, C and Liu, D and Weickert, CS and Weickert, TW, Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder, Schizophrenia Research, 213 pp. 87-95. ISSN 0920-9964 (2019) [Refereed Article]
Copyright Statement
Copyright 2019 Crown Copyright
DOI: doi:10.1016/j.schres.2019.06.026
Abstract
Altered levels of stress-signalling transcripts have been identified in post-mortem brains of people with
schizophrenia, and since stress effects may be expressed throughout the body, there should be similar
changes in peripheral cells. However, the extent to which these markers are altered in peripheral white
blood cells of people with schizophrenia is not known. Furthermore, how peripheral cortisol and stressrelated mRNA are associated with negative symptom severity and emotional states in people with
schizophrenia versus schizoaffective disorder has not been determined. Whole blood samples were
collected from 86 patients with either schizophrenia or schizoaffective disorder (56 people with
schizophrenia and 30 people with schizoaffective disorder), and 77 healthy controls. Total RNA was
isolated, cDNA was synthesized, and stress-signalling mRNA levels (for NR3C1, FKBP5, FKBP4, PTGES3
and BAG1) were determined. Stress and symptom severity scores were measured by the Depression,
Anxiety and Stress Scale, and the Positive and Negative Syndrome Scale, respectively. We found increased
FKBP5 mRNA, Z(156) ¼ 2.5, p ¼ 0.01, decreased FKBP4 mRNA, t(155) ¼ 3.5, p 0.001, and decreased
PTGES3 mRNA, t(153) ¼ 3.0, p 0.01, in schizophrenia and schizoaffective disorder cohorts combined
compared to healthy controls. Stress-related peripheral mRNA levels were differentially correlated with
negative emotional states and symptom severity in schizoaffective disorder (β's ¼ e0.45e0.56, p's ¼ 0.05
e0.001) and schizophrenia (β's ¼ 0.34e0.38, p's ¼ 0.04e0.03), respectively. Therefore, molecules of the
stress-signalling pathway appear to differentially contribute to clinical features of schizophrenia versus
schizoaffective disorder.
Item Details
Item Type: | Refereed Article |
---|---|
Keywords: | schizophrenia, schizoaffective disorder, stress, symptoms, emotions, stress signalling transcripts |
Research Division: | Health Sciences |
Research Group: | Health services and systems |
Research Field: | Mental health services |
Objective Division: | Health |
Objective Group: | Clinical health |
Objective Field: | Clinical health not elsewhere classified |
UTAS Author: | Sinclair, D (Dr Duncan Sinclair) |
ID Code: | 136902 |
Year Published: | 2019 |
Web of Science® Times Cited: | 12 |
Deposited By: | Wicking Dementia Research and Education Centre |
Deposited On: | 2020-01-22 |
Last Modified: | 2022-08-23 |
Downloads: | 0 |
Repository Staff Only: item control page